Cardiac myosin heavy chains lacking the light chain binding domain cause hypertrophic cardiomyopathy in mice

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 276, Issue 6 45-6, 1999, Pages

  Welikson, Robert E ^a,d   Buck, Scott H ^b   Patel, Jitandrakumar R ^b   Moss, Richard L ^b   Vikstrom, Karen L ^a,e   Factor, Stephen M ^c   Miyata, Setsuya ^a   Weinberger, Howard D ^f   Leinwand, Leslie A ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^f Campus Box 347 ^*

Author keywords

Myosin heavy chain; Transgenic mice; Valve disease

Indexed keywords

MYOSIN HEAVY CHAIN; MYOSIN LIGHT CHAIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; ECHOCARDIOGRAPHY; FEMALE; GENE MUTATION; HISTOLOGY; HYPERTROPHIC CARDIOMYOPATHY; MALE; MISSENSE MUTATION; MOUSE; MUSCLE CONTRACTION; NONHUMAN; PHOTOLYSIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; TRANSGENIC MOUSE; VALVULAR HEART DISEASE;

EID: 0033003018     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1999.276.6.h2148     Document Type: Article

References (50)

1. 2+ upon illumination. J. Am. Chem. Soc. 111: 7957-7968, 1989.
2. Anson, M., M. A. Geeves, S. E. Kurzawa, and D. J. Manstein. Myosin motors with artificial lever arms. EMBO J. 15: 6069-6074, 1996.
3. 2+. Am. J. Physiol. 267 (Heart Circ. Physiol. 36): H1643-H1653, 1994.
4. Arber, S., J. J. Hunter, J. Ross, Jr., M. Hongo, G. Sansig, J. Borg, J.-C. Perriard, K. R. Chien, and P. Caroni. MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilatated cardiomyopathy, and heart failure. Cell 88: 393-403, 1997.
5. Bishop, J. M., and G. I. Evan. Isolation of monoclonal antibodies specific for human c-myc protooncogene product. Mol. Cell Biol. 5: 3610-3616, 1985.
6. Bonne, G., L. Carrier, J. Bercovici, C. Cruaud, P. Richard, B. Hainque, M. Gautel, S. Labeit, M. James, J. Beckmann, J. Weissenbach, H. Vosberg, M. Fiszman, M. Komajda, and K. Schwartz. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nature Gen. 11: 438-440, 1995.
7. 2+ on cross-bridge turnover kinetics in skinned single rabbit psoas fibers: implications for regulation of muscle contraction. Proc. Natl. Acad. Sci. USA 85: 3265-3269, 1988.
8. 2+. Biophys. J. 67: 1994-2001, 1994.
9. Everett, A. W., G. Prior, W. A. Clark, and R. Zak. Quantitation of myosin in muscle. Anal. Biochem. 130: 102-107, 1983.
10. Fabiato, A. Computer programs for calculating total from specified free and free from specified total ionic concentrations in aqueous solutions containing multiple metals and ligands. Methods Enzymol. 157: 378-417, 1988.
11. Fitzsimons, D. P., J. R. Patel, and R. L. Moss. Role of myosin heavy chain composition on kinetics of force development and relaxation in rat myocardium. J. Physiol. (Lond.) 513: 171-183, 1998.
12. Geisterfer-Lowrance, A. A. T., M. Christe, D. A. Conner, J. S. Ingwall, F. J. Schoen, C. E. Seidman, and J. G. Seidman. A mouse model of familial hypertrophic cardiomyopathy. Science 272: 731-734, 1996.
13. Geisterfer-Lowrance, A. A. T., S. Kass, G. Tanigawa, H. Vosberg, W. McKenna, C. E. Seidman, and J. G. Seidman. A molecular basis for familial hypertrophic cardiomyopathy. A cardiac myosin heavy chain gene missense mutation. Cell 62: 999-1006, 1990.
14. Godt, R. E., and B. D. Lindley. Influence of temperature upon contractile activation and isometric force production in mechanically skinned muscle fibers of frog. J. Gen. Physiol. 80: 279-297, 1982.
15. Gustafson, T. A., J. J. Bahl, B. E. Markham, W. R. Roeske, and E. Morkin. Hormonal regulation of myosin heavy chain and α actin gene expression in cultured fetal rat heart myocytes. J. Biol. Chem. 262: 13316-13322, 1987.
16. 2+ sensitivities of isometric tension, stiffness, and velocity of shortening in skinned skeletal muscle fibers. J. Gen. Physiol. 95: 477-498, 1990.
17. Hogan, B., F. Constantini, and E. Lacy. Manipulating the Mouse Embryo. A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor, 1986.
18. Kaplan, J. H., and G. C. R. Ellis-Davies. Photolabile chelators for the rapid photorelease of divalent cations. Proc. Natl. Acad. Sci. USA 85: 6571-6575, 1988.
19. Klues, H. G., B. J. Maron, A. L. Dollar, and W. C. Roberts. Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy. Circulation 85: 1651-1660, 1992.
20. Klues, H. G., A. Schiffers, and B. J. Maron. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J. Am. Coll. Cardiol. 26: 1699-1708, 1995.
21. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
22. Lankford, E. B., N. D. Epstein, L. Fananapazir, and H. L. Sweeney. Abnormal contractile properties of muscle fibers expressing β-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. J. Clin. Invest. 95: 1409-1414, 1995.
23. Lowey, S., G. S. Waller, and K. M. Trybus. Skeletal muscle myosin light chains are essential for physiological speeds of shortening. Nature 365: 454-456, 1993.
24. Maron, B. J., R. O. Bonow, R. O. Cannon, M. B. Leon, and S. E. Epstein. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1). N. Engl. J. Med. 316: 780-789, 1987.
25. McLachlan, A. D., and J. Karn. Periodic charge distributions in the myosin rod amino acid sequence match cross-bridge spacings in muscle. Nature 299: 226-230, 1982.
26. McNally, E., M. Bravo-Zehnder, and L. A. Leinwand. Identification of sequences necessary for the association of cardiac myosin subunits. J. Cell Biol. 113: 585-590, 1991.
27. McNally, E. M., K. M. Gianola, and L. A. Leinwand. Complete nucleotide sequence of full length cDNA for rat α myosin heavy chain. Nucleic Acids Res. 17: 7527-7528, 1989.
28. 797Thr mutation in exon 21 of the beta myosin heavy chain gene in hypertrophic cardiomyopathy. Hum. Mutat. 6: 197-198, 1995.
29. Nadal-Ginard, B., and V. Mahdavi. Molecular basis of cardiac performance. Plasticity of the myocardium generated through protein isoform switches. J. Clin. Invest. 84: 1693-1700, 1989.
30. 2+ sensitizers caffeine and CGP 48506 on the relaxation rate of rat skinned cardiac trabeculae. Circ. Res. 80: 682-687, 1997.
31. 2- fluorophore. J. Biol. Chem. 272: 6018-6027, 1997.
32. Poetter, K., H. Jiang, S. Hassanzadeh, S. R. Master, A. Chang, M. C. Dalakas, I. Rayment, J. R. Sellers, L. Fananapazir, and N. D. Epstein. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat. Genet. 13: 63-69, 1996.
33. Rayment, I., H. M. Holden, J. R. Sellers, L. Fananapazir, and N. D. Epstein. Structural interpretation of the mutations in the β-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy. Proc. Natl. Acad. Sci. USA 92: 3864-3868, 1995.
34. Rayment, I., H. M. Holden, M. Whittaker, C. B. Yohn, M. Lorenz, K. C. Holmes, and R. A. Milligan. Structure of the actin-myosin complex and its implications for muscle contraction. Science 261: 58-65, 1993.
35. Regnier, M., D. A. Martyn, and P. B. Chase. Calcium regulation of tension redevelopment kinetics with 2-deoxy-ATP or low [ATP] in rabbit skeletal muscle. Biophys. J. 74: 2005-2015, 1998.
36. Sata, M., and M. Ikebe. Functional analysis of the mutations in the human cardiac β-myosin that are responsible for familial hypertrophic cardiomyopathy. J. Clin. Invest. 98: 2866-2873, 1996.
37. Solaro, R. J., D. C. Pang, and N. Briggs. The purification of cardiac myofibrils with Triton X-100. Biochim. Biophys. Acta 245: 259-262, 1971.
38. Strang, K. T., N. K. Sweitzer, M. L. Greaser, and R. L. Moss. α-Adrenergic receptor stimulation increases unloaded shortening velocity of skinned single ventricular myocytes from rats. Circ. Res. 74: 542-549, 1994.
39. Sweeney, H. L., A. J. Straceski, L. A. Leinwand, and L. Faust. Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction. J. Biol. Chem. 269: 1603-1605, 1994.
40. Tantravahi, J., M. Alvira, and E. Falck-Pedersen. Characterization of the mouse β maj globin transcription termination region: a spacing sequence is required between the poly(A) signal sequence and multiple downstream termination elements. Mol. Cell. Biol. 13: 578-587, 1993.
41. Thierfelder, L., H. Watkins, C. MacRae, R. Lamas, W. McKenna, H. Vosberg, J. G. Seidman, and C. E. Seidman. α-Tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 77: 701-712, 1994.
42. Towbin, M., T. Staehelin, and J. Gordon. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedures and some applications. Proc. Natl. Acad. Sci. USA 76: 4350-4354, 1979.
43. Uyeda, T. Q. P., P. D. Abramson, and J. A. Spudich. The neck region of the myosin motor domain acts as a lever arm to generate movement. Proc. Natl. Acad. Sci. USA 93: 4459-4464, 1996.
44. Uyeda, T. Q. P., and J. A. Spudich. A functional recombinant myosin II lacking a regulatory light chain-binding site. Science 262: 1867-1869, 1993.
45. Vikstrom, K. L., S. M. Factor, and L. A. Leinwand. Mice expressing mutant myosin are a model for hypertrophic cardiomyopathy. Mol. Med. 2: 556-567, 1996.
46. Vikstrom, K. L., and L. A. Leinwand. Contractile protein mutations and heart disease. Curr. Opin. Cell Biol. 8: 97-105, 1996.
47. Vikstrom, K. L., A. S. Rovner, M. Bravo-Zehnder, C. G. Saez, A. J. Straceski, and L. A. Leinwand. Sarcomeric myosin heavy chain expressed in nonmuscle cells forms thick filaments in the presence of substoichiometric amounts of light chains. Cell Motil. Cytoskeleton 26: 192-204, 1993.
48. Warrick, H. M., and J. A. Spudich. Myosin structure and function in cell motility. Annu. Rev. Cell Biol. 3: 379-421, 1987.
49. Wolff, M. W., K. S. McDonald, and R. L. Moss. Rate of tension development in cardiac muscle varies with the level of activator calcium. Circ. Res. 76: 154-160, 1995.
50. Zhang, R., J. Zhao., A. Mandveno, and J. D. Potter. Cardiac troponin I phosphorylation increases the rate of cardiac muscle relaxation. Circ. Res. 76: 1028-1035, 1995.